While the ICBC Berlin in April offers the major mass industry gathering, the tenth edition of World Class Cannabis Business Europe on May 19-20, 2026 in Frankfurt am Main takes the opposite approach. The curated closed-door format brings together 200 senior executives from 150 companies. The concept targets decision-makers who write contracts rather than exchange business cards.
📑 Inhaltsverzeichnis
Tenth Edition Under New Circumstances
The event arrives in a market in transition. According to Prohibition Partners data, Germany in 2026 accounts for more than half of Europe’s medical cannabis imports and serves as a hub for global supply. Simultaneously, recent German Federal Court of Justice (BGH) advertising rulings, discussions around statutory health insurance reimbursement, and the draft Medical Cannabis Act are moderating short-term market dynamics. The conference positions itself precisely within this tension. Instead of public traffic and exhibition theater, the organizer promises two days of case studies, round tables, and in-depth networking slots at the Leonardo Hotel Frankfurt City South.
Those seeking an overview of parallel European industry meetings will find it in our guide to Cannabis Europe 2026 in London as well as our report on CannaTrade 2026 in Zurich.
Who Takes the Stage
The speaker list reads like a selection of DACH-relevant supply chains. Torsten Greif, managing partner of Four 20 Pharma, represents the Paderborn-based EU-GMP producer recently acquired in full by Curaleaf. Aurora Europe sends Sales Director Marcus Reussmann. The Canadian heavyweight has recently directed a record share of its cannabis flower exports to Germany, as our analysis of Canadian supply chains demonstrates. Canopy Growth is represented by Senior Vice President Andrew Bevan. Additional speakers include representatives from pharmaceutical logistics, import licensing consultation, and investment banking. The event thus bundles those actors who must operationally manage the transition from hype cycle to regulated pharmaceutical reality.
Frankfurt as Strategic Hub
The choice of venue is no coincidence. Frankfurt is not only a logistics hub for pharmaceutical imports but also hosts the Paul Ehrlich Institute and a dense landscape of law firms representing essential regulatory interfaces. Add to this short distances to pharmaceutical wholesalers and proximity to the just-concluded ICBC season in Berlin. Those seeking to sort through business cards one more time in May before summer begins will find a concentrated format here. Tickets range from 499 euros for the conference pass to 1,999 euros for consultants, investors, and service providers without direct cannabis involvement.
2026 Theme Focus
Programmatically, much revolves around three axes. First, the consolidation wave following the BGH ruling, insolvencies, and recent M&A activity—including Curaleaf’s complete acquisition of Four 20 Pharma and Organigram’s purchase of Sanity Group for up to 250 million euros. Second, import-side logistics, as Jersey, Spain, and Portugal emerge as new EU-GMP hubs to supplement German demand. Third, compliance management following three BGH advertising rulings from March 2026 applying the Medicinal Products Advertising Act to telemedicine platforms. Round tables on market studies, patient supply, and pharmacy dialogue round out the program. Organizers explicitly emphasize a German market focus stronger than in previous years.
Frequently Asked Questions
When and where does World Class Cannabis Business Europe 2026 take place?
The tenth edition runs May 19-20, 2026 at Leonardo Hotel Frankfurt City South in Frankfurt am Main. The organizer is World Class Business Leaders platform, represented by Cannabis Events Lead Darius Zheng.
Who is the event aimed at?
Target audiences are senior executives from approximately 150 companies in the European medical cannabis, CBD, and hemp industry. Focus areas include decision-makers in production, distribution, pharmacy chains, legal, and investment.
How does the format differ from ICBC, Cannabis Europe, or CannaTrade?
While ICBC and CannaTrade target thousands of visitors and large exhibition spaces, WCCBE is deliberately kept small. 200 participants, curated round tables, and a condensed two-day program enable networking depth over reach.
What do tickets cost?
The standard conference pass starts at 499 euros. Consultants, investors, and solution providers without direct cannabis involvement pay 1,999 euros. Early-bird discounts are communicated via the organizer’s website.
Which DACH speakers are particularly relevant?
Torsten Greif, managing partner of Four 20 Pharma in Paderborn, and Marcus Reussmann of Aurora Europe are the central DACH voices. Both companies significantly shape German medical cannabis supply.
Sources: krautinvest.de (01.24.2026), worldclassbusinessleaders.com/events/cbe26, cannabistech.com.
Welches Format bringt dich beruflich im Cannabis-Business weiter?
Branchen-Update
News, Analysen und Reportagen — mehrmals im Monat direkt in dein Postfach.
Folge uns
